A Study of Lenalidomide in Patients with Chronic Lymphocytic Leukemia and Residual Disease after Chemotherapy - RV-CLL-PI-0270
Phase of Trial: Phase II
Latest Information Update: 20 Oct 2015
At a glance
- Drugs Lenalidomide (Primary)
- Indications Chronic lymphocytic leukaemia
- Focus Therapeutic Use
- 14 Oct 2015 Status changed from active, no longer recruiting to completed, according to ClinicalTrials.gov record.
- 09 Jan 2015 Status changed from recruiting to active, no longer recruiting as reported by M.D. Anderson Cancer Center record.
- 09 Apr 2014 Planned End Date changed from 1 Aug 2015 to 1 Aug 2016 as reported by ClinicalTrials.gov.